Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>The FDA&rsquo;s recent move to allow a waiver of informed consent for studies involving minimal risk could be a first step toward harmonization with the existing Common Rule.</p>

FDA’s Informed Consent Change Is Step Toward Harmonizing

And what about the revised Common Rule?